EQL — EQL Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK670.32m
- SEK1.07bn
- SEK432.66m
Brief: EQL Pharma Q3 EBIT SEK 14.8 Million
Brief: EQL Pharma Issues Senior Secured Bonds Of SEK 350 Mln Under SEK 700 Mln Framework
Brief: EQL Pharma Considers Issuing Senior Secured Bonds
Brief: EQL Pharma Signs Binding Asset Purchase Agreement For DKK 120 Mln
Brief: EQL Pharma Expects Growth Rate Of Around 40% For Full Year 2024/25
Brief: EQL Pharma Q2 EBIT SEK 14.3 Million
Brief: EQL Pharma Q1 EBIT SEK 15.2 Million
Brief: Eql Pharma AB Says Qtrly Consolidated Sales Amounted To Sek 78.1(60.3)Million, An Increase Of 30%
Brief: EQL Pharma Q4 EBIT SEK 8.4 Million
Brief: Eql Pharma AB Says Qtrly EBIT Amounted To SEK 9.8 (15.5) Million, A Decrease Of 37%
Brief: EQL Pharma Q2 EBIT SEK 6.6 Million
Brief: EQL Pharma Q1 Adjusted Revenue SEK 56.2 Million
Brief: EQL Pharma Q4 EBIT Margin at 10%
Brief: EQL Pharma Posts Revised Offer for Sensidose
Brief: EQL Pharma Q3 EBIT SEK 15.5 Million
Brief: EQL Pharma AB Says Christer Fåhraeus Was Elected As New Chairman Of Board Of Directors.
Brief: Eql Pharma Reports Q1 Ebit Amounted To SEK 7.9 Mln
Brief: EQL Pharma Reports Group's Sales During Q1 Amounted To SEK 37.3 (99.5) Mln
Brief: EQL Chooses To Postpone The List Change To Nasdaq Stockholm